STOCK TITAN

[Form 4] Cerence Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Brian M. Krzanich, a Director and the Chief Executive Officer of Cerence Inc. (CRNC), reported a disposition of 132,075 shares of common stock on 10/09/2025 at a reported sale price of $11.4585 per share. After the reported transaction, the reporting person beneficially owned 905,987 shares. The filing explains the sale represented a mandatory "sell to cover" to satisfy tax withholding for vested restricted stock units and was not a discretionary trade by the reporting person. The Form 4 was signed on 10/10/2025 by an attorney-in-fact.

Brian M. Krzanich, un Direttore e il Chief Executive Officer di Cerence Inc. (CRNC), ha riportato una disposizione di 132,075 azioni ordinarie in 10/09/2025 a un prezzo di vendita riportato di $11.4585 per azione. Dopo la transazione riportata, la persona riportante possedeva beneficiamente 905,987 azioni. Il deposito spiega che la vendita rappresentava una obbligatoria "sell to cover" per soddisfare le trattenute fiscali sui restricted stock units vestite e non era una negoziazione discrezionale da parte della persona che riporta. Il Form 4 è stato firmato l'10/10/2025 da un procuratore speciale.

Brian M. Krzanich, un Director y el Chief Executive Officer de Cerence Inc. (CRNC), informó una disposición de 132,075 acciones ordinarias en 10/09/2025 a un precio de venta reportado de $11.4585 por acción. Después de la transacción reportada, la persona que reporta poseía beneficiosamente 905,987 acciones. El archivo explica que la venta representó una venta obligatoria para cubrir impuestos por las unidades de acciones restringidas vestidas y no fue una operación discrecional por parte de la persona que reporta. El Formulario 4 fue firmado el 10/10/2025 por un apoderado.

Brian M. Krzanich은 Cerence Inc. (CRNC)의 이사이자 최고경영자로서, 132,075 주의 일반주를 10/09/2025에 보고된 매도가격 $11.4585로 매도했다고 보고했다. 보고된 거래 이후, 보고자은 혜택적으로 905,987 주를 소유하게 되었다. 공시는 매도가 vesting된 제한주식단위에 대한 세금 원천징수를 충당하기 위한 의무적 'Sell to Cover'였으며 보고자의 재량 거래가 아니었음을 설명한다. Form 4는 10/10/2025에 대리인에 의해 서명되었다.

Brian M. Krzanich, un Directeur et le CEO de Cerence Inc. (CRNC), a fait état d’une disposition de 132 075 actions ordinaires le 10/09/2025 à un prix de vente déclaré de $11.4585 par action. Après la transaction déclarée, la personne déclarant détenait bénévolement 905 987 actions. Le dépôt explique que la vente représentait une obligation « sell to cover » pour satisfaire les retenues d’impôt sur les unités d’actions restreintes acquises et n’était pas une opération discrétionnaire de la part de la personne déclarant. Le Form 4 a été signé le 10/10/2025 par un mandataire.

Brian M. Krzanich, ein Director und der Chief Executive Officer von Cerence Inc. (CRNC), meldete eine Veräußerung von 132,075 Stammaktien am 10/09/2025 zu einem gemeldeten Verkaufspreis von $11.4585 pro Aktie. Nach der gemeldeten Transaktion besaß die meldende Person vorteilhaft 905,987 Aktien. Die Einreichung erklärt, dass der Verkauf eine verpflichtende „Sell to Cover“ war, um die Steuerabzüge für vestete Restricted Stock Units zu tilgen, und kein freier Handel durch die meldende Person darstellte. Das Formular 4 wurde am 10/10/2025 von einem Bevollmächtigten unterzeichnet.

برايان م. كرانيتش، مدير والرئيس التنفيذي لشركة Cerence Inc. (CRNC)، أبلغ عن تصرف في 132,075 سهماً من الأسهم العادية في 10/09/2025 بسعر بيع مذكور قدره $11.4585 للسهم الواحد. بعد الصفقة المعلنة، امتلك الشخص المعلن عن التصرف بشكل مستفيد 905,987 سهماً. يشرح الملف أن البيع مثل إجراء "بيع لتغطية" إلزامي لتسديد حجز الضرائب على وحدات الأسهم المقيدة المحققة vesting وأنه لم يكن تداولاً اختيارياً من قبل الشخص المعلن. تم توقيع النموذج 4 في 10/10/2025 من قبل وكيل.

布莱恩·M·克扎尼奇,为 Cerence Inc. (CRNC)的 董事首席执行官,报告在 10/09/2025 以每股 $11.4585 的已披露出售价格处置了 132,075 股普通股。交易后,该报告人实益拥有 905,987 股。文件说明该出售是为确保对已归属的受限股单位的税款预扣而进行的强制性“卖出以覆盖”(sell to cover),并非报告人自愿交易。Form 4 于 10/10/2025 由代理人签署。

Positive
  • Sale was a mandated 'sell-to-cover' for RSU tax withholding, not a discretionary trade
  • Reporting person retains significant stake with 905,987 shares beneficially owned after the sale
Negative
  • Beneficial ownership decreased by 132,075 shares following the disposition on 10/09/2025
  • Transaction was reported as a sale which, while routine, reduces the insider's public holding

Insights

Insider sale was procedural, not an active cash-out decision.

The transaction is disclosed as a mandated sell-to-cover tied to the vesting of restricted stock units, which means the company elected to satisfy tax-withholding obligations by selling a portion of shares rather than requiring an out‑of‑pocket tax payment from the insider. This preserves the insider's net equity position while covering taxes.

Dependencies and risks include the company's equity plan mechanics and any future vesting schedules; investors may note the post-transaction holding of 905,987 shares as the continuing insider stake. Monitor future Form 4 filings for additional vesting-related sales or discretionary trades within the next 12 months.

The sale reduced beneficial ownership but was routine and explicitly non-discretionary.

A reported disposition of 132,075 shares at $11.4585 per share lowers the insider's public holding count; however, the filing states the sale was executed solely to meet tax withholding on vested RSUs, not to generate liquidity. That distinction matters for interpreting insider intent.

For market impact, note the transaction date 10/09/2025 and the remaining 905,987 shares beneficially owned. Watch subsequent filings or company announcements for additional vesting events or changes to the equity compensation policy over the next year.

Brian M. Krzanich, un Direttore e il Chief Executive Officer di Cerence Inc. (CRNC), ha riportato una disposizione di 132,075 azioni ordinarie in 10/09/2025 a un prezzo di vendita riportato di $11.4585 per azione. Dopo la transazione riportata, la persona riportante possedeva beneficiamente 905,987 azioni. Il deposito spiega che la vendita rappresentava una obbligatoria "sell to cover" per soddisfare le trattenute fiscali sui restricted stock units vestite e non era una negoziazione discrezionale da parte della persona che riporta. Il Form 4 è stato firmato l'10/10/2025 da un procuratore speciale.

Brian M. Krzanich, un Director y el Chief Executive Officer de Cerence Inc. (CRNC), informó una disposición de 132,075 acciones ordinarias en 10/09/2025 a un precio de venta reportado de $11.4585 por acción. Después de la transacción reportada, la persona que reporta poseía beneficiosamente 905,987 acciones. El archivo explica que la venta representó una venta obligatoria para cubrir impuestos por las unidades de acciones restringidas vestidas y no fue una operación discrecional por parte de la persona que reporta. El Formulario 4 fue firmado el 10/10/2025 por un apoderado.

Brian M. Krzanich은 Cerence Inc. (CRNC)의 이사이자 최고경영자로서, 132,075 주의 일반주를 10/09/2025에 보고된 매도가격 $11.4585로 매도했다고 보고했다. 보고된 거래 이후, 보고자은 혜택적으로 905,987 주를 소유하게 되었다. 공시는 매도가 vesting된 제한주식단위에 대한 세금 원천징수를 충당하기 위한 의무적 'Sell to Cover'였으며 보고자의 재량 거래가 아니었음을 설명한다. Form 4는 10/10/2025에 대리인에 의해 서명되었다.

Brian M. Krzanich, un Directeur et le CEO de Cerence Inc. (CRNC), a fait état d’une disposition de 132 075 actions ordinaires le 10/09/2025 à un prix de vente déclaré de $11.4585 par action. Après la transaction déclarée, la personne déclarant détenait bénévolement 905 987 actions. Le dépôt explique que la vente représentait une obligation « sell to cover » pour satisfaire les retenues d’impôt sur les unités d’actions restreintes acquises et n’était pas une opération discrétionnaire de la part de la personne déclarant. Le Form 4 a été signé le 10/10/2025 par un mandataire.

Brian M. Krzanich, ein Director und der Chief Executive Officer von Cerence Inc. (CRNC), meldete eine Veräußerung von 132,075 Stammaktien am 10/09/2025 zu einem gemeldeten Verkaufspreis von $11.4585 pro Aktie. Nach der gemeldeten Transaktion besaß die meldende Person vorteilhaft 905,987 Aktien. Die Einreichung erklärt, dass der Verkauf eine verpflichtende „Sell to Cover“ war, um die Steuerabzüge für vestete Restricted Stock Units zu tilgen, und kein freier Handel durch die meldende Person darstellte. Das Formular 4 wurde am 10/10/2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krzanich Brian M

(Last) (First) (Middle)
25 MALL ROAD
SUITE 416

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/09/2025 S 132,075(1) D $11.4585 905,987 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Remarks:
/s/ Jennifer Salinas, Attorney-in-Fact 10/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cerence (CRNC) insider Brian Krzanich report on the Form 4?

The Form 4 reports a disposition of 132,075 shares on 10/09/2025 at $11.4585 per share, leaving 905,987 shares beneficially owned.

Was the sale by the CRNC insider discretionary?

No. The filing states the sale was a mandatory 'sell to cover' transaction to satisfy tax withholding on vested restricted stock units, not a discretionary sale.

How does a 'sell to cover' affect insider holdings?

A 'sell to cover' reduces the number of shares held to pay taxes on vested RSUs while allowing the insider to retain the remaining vested shares; here it resulted in a reported disposition of 132,075 shares.

When was the Form 4 signed for this transaction?

The Form 4 bears a signature by an attorney-in-fact on 10/10/2025.

What is the insider's title at Cerence (CRNC)?

The reporting person, Brian M. Krzanich, is listed as a Director and the Chief Executive Officer.
Cerence Inc

NASDAQ:CRNC

CRNC Rankings

CRNC Latest News

CRNC Latest SEC Filings

CRNC Stock Data

505.54M
40.01M
7.47%
71.94%
18.31%
Software - Application
Services-prepackaged Software
Link
United States
BURLINGTON